AOD-9604 — HGH Fragment Lipolysis Research

Last updated: May 2026

AOD-9604 is a synthetic 16-amino-acid peptide corresponding to residues 176 to 191 of human growth hormone (HGH). The full HGH molecule is 191 amino acids long. AOD-9604 is the C-end region. Experts found it responsible for the lipolytic action of HGH in lab studies. Unlike full HGH. AOD-9604 does not appear to bind the insulin receptor or influence IGF-1 levels in the same way. According to a review in Obesity Research (2001). AOD-9604 showed fat metabolism effects in rodent models. It does this without the diabetogenic action linked to full-length growth hormone.

Next Level Pharm supplies research-grade AOD-9604 tested to at least 99 percent purity by HPLC. Mass spec on every batch. HPLC measures compound purity by separating components in a sample. Mass spec confirms the molecule weight matches the 16-amino-acid chain. A Certificate of Test ships with every lot.

The sections below cover AOD-9604’s relationship to HGH, the fat breakdown pathway, which animal studies describe. What to check when sourcing.

Key Takeaways

What it is: AOD-9604 is a 16-amino-acid synthetic fragment of human growth hormone (residues 176-191). It is studied for its effects on lipid metabolism in animal models.
Pathway: AOD-9604 is linked to beta-3 adrenergic receptor trigger. Fat breakdown (fat breakdown from adipocytes) in rodent research without IGF-1 rise.
HGH comparison: Unlike full HGH, AOD-9604 does not appear to trigger the insulin receptor pathway. Reduces diabetogenic action in animal models.
Research scope: All AOD-9604 findings come from lab and early trial-based research. No therapeutic claims are supported for research-grade material.
Sourcing standard: Research-grade AOD-9604 needs HPLC purity above 99 percent, mass spec proof. A lot-exact Certificate of Test.

Here is a closer look at each research area, what published studies describe. What experts should know before sourcing.

What Is AOD-9604 and How Does It Relate to HGH?

Human growth hormone (HGH) is a 191-amino-acid peptide produced in the pituitary gland. HGH has many living actions. It boosts IGF-1 output. It influences protein output, glucose metabolism, and lipid breakdown. experts found that different regions of HGH are responsible for different actions.

The C-end region of HGH, in particular residues 176 to 191. Was found to carry lipolytic action in the cell. Animal studies. According to a study in Molecular. Cellular Endocrinology (1999). This 16-amino-acid region boosted fat breakdown from adipocytes with minimal effect on IGF-1 levels. AOD-9604 is the synthetic version of this fragment. It allows experts to study the lipolytic region of HGH. It does this without the other actions of the full molecule.

What Does the Lipolysis Mechanism Research Show?

Fat breakdown is the breakdown of stored fat (triglycerides) into free fatty acids and glycerol. Adipocytes are the cells that store fat. When fat breakdown is triggered, triglycerides inside adipocytes are broken down and released into circulation. This process is controlled by several receptor systems, including beta-adrenergic receptors.

AOD-9604 is thought to trigger fat breakdown through beta-3 adrenergic receptor boost in adipocyte cell models. Beta-3 adrenergic receptors are found on fat cells. Their trigger leads to hormone-sensitive lipase (HSL) phosphorylation, which breaks down stored triglycerides. According to a study in Endocrinology (2000). AOD-9604 showed adipocyte fat breakdown effects in cell culture models using this receptor pathway. The same study described that IGF-1 levels were not raised in AOD-9604 treated cell models. Is a notable difference from full HGH.

Browse research-grade AOD-9604 at Next Level Pharm for COA-tested options with full lot records.

How Does AOD-9604 Differ from Full HGH in Studies?

Full HGH triggers many receptor systems. It binds the GH receptor to boost IGF-1 output, and affects glucose transport through insulin receptor cross-reactivity. Triggers fat breakdown through adrenergic pathways. Each of these actions has different downstream effects in animal and human models.

AOD-9604 appears to isolate the lipolytic action without activating the insulin receptor pathway. According to a review in the Journal of Endocrinology (2003), rodent studies showed. AOD-9604 produced similar fat metabolism effects to full HGH at the adipocyte level. It did not cause the hyperglycemia or IGF-1 rise seen with full HGH in the same models. This mechanistic separation is the main reason experts use AOD-9604. It aimed to study metabolism in particular.

What Do Animal Studies Show for AOD-9604?

Animal studies for AOD-9604 used primarily mouse and rat models of diet-induced obesity or metabolic dysfunction. These studies examined fat depot changes, adipocyte size. Metabolic marker shifts in treated groups compared to controls.

Published rodent model data described reduced visceral fat deposits in obese mouse models after AOD-9604 treatment compared to placebo groups. According to a study in Obesity Research (2001). Obese mice given AOD-9604 showed changes in fat depot composition. It was similar in direction to full HGH. Without the metabolic side effects found in HGH-treated controls. These animal model findings are in the lab. They cannot be directly applied to human physiology without trial-based trial evidence.

What Does Cartilage and Bone Research Show?

Beyond fat metabolism, some published research has examined AOD-9604 for effects on cartilage and bone tissue. This research area emerged from finding that HGH fragments affect many tissue types. Cartilage and bone repair models have been tested with AOD-9604 in both cell cultures. Animal experiments.

According to a study in the Journal of Peptide Science (2012). AOD-9604 showed effects on chondrocyte change. Cartilage matrix markers in cell culture experiments. The proposed pathway involves the same C-end HGH region interacting with cartilage progenitor cells. This research area is smaller than the fat metabolism research. It is described as early and needs further study in controlled animals. Trial-based models before any conclusions can be drawn.

How Is Research-Grade AOD-9604 Sourced?

Research-grade AOD-9604 needs HPLC purity at 99 percent or above. Mass spec proof of the 16-amino-acid chain. A lot-exact Certificate of Test. The HPLC and mass spec records confirm type and purity. The COA provides lot-level traceability.

AOD-9604 is supplied as a lyophilized powder. Lyophilization removes moisture through freeze-drying under vacuum. This process extends shelf life and allows room-temperature shipping. Cold-chain handling is not needed for properly prepared lyophilized peptides. Storage after receipt should follow the lot-exact COA. Products without lot-exact records cannot confirm batch consistency for reproducible research.

Feature	AOD-9604	Full HGH
Amino acid count	16	191
Region of HGH	Residues 176-191 (C-terminal)	Full sequence
IGF-1 elevation	Not reported in animal models	Yes, a primary effect
Insulin receptor binding	Not reported	Yes, cross-reactivity observed
Lipolysis activity	Yes, via beta-3 adrenergic pathway	Yes, one of multiple effects
Research use	Isolated fat metabolism studies	Full GH axis research

Frequently Asked Questions

What is AOD-9604?

AOD-9604 is a 16-amino-acid synthetic peptide corresponding to residues 176 to 191 of human growth hormone (HGH). It is studied for its effects on lipid metabolism and adipocyte fat breakdown in animal models. AOD-9604 is for lab research only. It is not approved for human use. Purity is tested to at least 99 percent by HPLC. Mass spec on every batch shipped.

How does AOD-9604 relate to HGH?

HGH is a 191-amino-acid pituitary peptide with many living actions. AOD-9604 is the synthetic C-end fragment of HGH covering residues 176 to 191. Research found this region as carrying the lipolytic action of the full molecule. AOD-9604 allows experts to study fat metabolism effects. It does this without the IGF-1 rise or insulin receptor cross-reactivity linked to full HGH. This mechanistic separation makes it useful for isolated fat metabolism research.

What is lipolysis and how does AOD-9604 affect it in studies?

Fat breakdown is the breakdown of stored triglycerides in fat cells into free fatty acids. Glycerol. AOD-9604 has been linked to fat breakdown through beta-3 adrenergic receptor triggers in adipocyte cell models. Beta-3 receptors on fat cells, when triggered, trigger hormone-sensitive lipase (HSL) to break down stored fat. Published cell culture data described fat breakdown effects for AOD-9604 without IGF-1 co-rise. Animal model data described fat depot changes consistent with this pathway.

Does AOD-9604 affect IGF-1 levels?

Published animal and cell studies have not linked AOD-9604 to clear IGF-1 rise. This contrasts with full HGH, which boosts IGF-1 output as a primary effect. The mechanistic separation is due to the specificity of AOD-9604 for the C-end lipolytic region of HGH rather than the IGF-1-boosting N-end domain. experts use this feature to study fat metabolism pathways. It does this without the confounding effects of raised IGF-1 on other lab outcomes.

What animal models have been used in AOD-9604 research?

Mouse and rat models of diet-induced obesity are the most common in published AOD-9604 research. These models use high-fat diet protocols to create excess fat buildup before studying compound effects. Published rodent studies examined fat depot composition, adipocyte size. Metabolic markers in treated versus control groups. Results showed fat composition changes consistent with fat breakdown action. All animal model findings are lab. They do not directly predict human responses.

Has AOD-9604 been studied in clinical trials?

AOD-9604 has been studied in early-phase trial-based research contexts. Some small-scale human studies were conducted primarily in Australia, where the compound was developed. These studies examined metabolic markers in participants. However, AOD-9604 did not receive control approval based on these studies. The research-grade compound is for lab research only. It is not a therapeutic agent. Should not be compared to any approved drug or treatment.

What purity is required for research-grade AOD-9604?

Research-grade AOD-9604 is tested to at least 99 percent purity by HPLC. Mass spec confirms the molecule weight matches the 16-amino-acid chain corresponding to HGH residues 176 to 191. A Certificate of Test for the exact lot records both results. These three records are the minimum standard for reproducible lab research. Full lot records ships with every AOD-9604 order to all 50 states.

Does AOD-9604 require cold-chain shipping?

Lyophilized AOD-9604 is stable at room temperature during shipping. Lyophilization removes moisture by freeze-drying under vacuum. Keeps the peptide stable without refrigeration during transit. Cold-chain handling is not needed for properly prepared lyophilized material. After receipt, refrigerated storage at 2 to 8 degrees Celsius is standard. The exact storage guidance for each lot is listed on the Certificate of Test.

Summary

AOD-9604 is a 16-amino-acid synthetic fragment of HGH covering residues 176 to 191. It is studied for fat breakdown action through beta-3 adrenergic receptor boost in adipocyte cell models.

Key features are the separation of lipolytic action from IGF-1 rise. Insulin receptor link seen with full HGH. Animal model data described fat depot changes consistent with fat breakdown. Cartilage and bone tissue research is smaller and more early. Research-grade sourcing needs HPLC purity above 99 percent, mass spec proof, and lot-exact COA records.

What Should You Do Next?

If you are studying AOD-9604 for lipid metabolism research, here is how to approach sourcing:

Match the research context to published model systems. Cell culture models use adipocyte assays. Animal models use diet-induced obesity protocols. Each system needs different lab controls.
Review the full HGH research to understand what AOD-9604 isolates. What it does not replicate from the full molecule.
Browse research-grade AOD-9604 at Next Level Pharm for COA-tested options with full lot records.

About the Author

Next Level Pharm Research Team

Alex M covers peer-reviewed findings in peptide science for Next Level Pharm, a US-based supplier of research-grade peptides verified to >=99% purity via HPLC and mass spectrometry on every batch.

Disclaimer: The information provided on this page is for educational and research purposes only. Next Level Pharm’s products are intended for laboratory research use only. They are not intended for human consumption, diagnostic, therapeutic, or medicinal purposes. This content does not constitute medical advice. Always consult a licensed healthcare professional before making any health-related decisions.

AOD-9604 Research: What Studies Show About This HGH Fragment